InsidersTradesSigma
Browse the complete record of transactions filed by Axel Schörling, 首席执行官. Officer active across 2 companies, notably EQL Pharma AB. Cumulatively, 4 reports have been recorded. History available since 16 May 2025. The latest transaction was filed on 27 March 2026 (Sale). Regulator: FIN-FSA. The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Axel Schörling is the Chief Executive Officer of EQL Pharma AB, a company specializing in drug development. Under his leadership, EQL Pharma focuses on innovation and improving medical treatments. His leadership is crucial for the growth and development of the company in the pharmaceutical market.